Compare XYF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XYF | OSUR |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.0M | 254.5M |
| IPO Year | 2018 | 2000 |
| Metric | XYF | OSUR |
|---|---|---|
| Price | $5.33 | $3.85 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 74.5K | ★ 501.8K |
| Earning Date | 05-18-2026 | 05-06-2026 |
| Dividend Yield | ★ 11.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | $0.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.30 | $2.08 |
| 52 Week High | $14.86 | $4.58 |
| Indicator | XYF | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 55.40 |
| Support Level | $4.98 | $3.70 |
| Resistance Level | $5.15 | $3.93 |
| Average True Range (ATR) | 0.25 | 0.16 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 49.67 | 69.74 |
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.